TITLE

Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods

AUTHOR(S)
Dunn, Graham; Maracy, Mohammad; Tomenson, Barbara
PUB. DATE
August 2005
SOURCE
Statistical Methods in Medical Research;Aug2005, Vol. 14 Issue 4, p369
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of examples and then introduce instrumental variable methods for the analysis of such trials. We concentrate mainly on situations in which compliance is all or nothing (either the patient receives the allocated treatment or they do not--in the latter case they may receive no treatment or a treatment other than the one allocated). The main purpose of the review is to illustrate the use of latent class (finite mixture) models, using maximum likelihood, for complier-average causal effect estimation under varying assumptions concerning the mechanism of the missing outcome data.
ACCESSION #
17644727

 

Related Articles

  • A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials. Selker, H P; Oye, K A; Eichler, H-G; Stockbridge, N L; Mehta, C R; Kaitin, K I; McElwee, N E; Honig, P K; Erban, J K; D'Agostino, R B // Clinical Pharmacology & Therapeutics;Feb2014, Vol. 95 Issue 2, p147 

    We propose an 'efficacy-to-effectiveness' (E2E) clinical trial design, in which an effectiveness trial would commence seamlessly upon completion of the efficacy trial. Efficacy trials use inclusion/exclusion criteria to produce relatively homogeneous samples of participants with the target...

  • Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. Pildal, Julie; Chan, An-Wen; Hrobjartsson, Asbjorn; Forfang, Elisabeth; Altman, Douglas G.; Gotzsche, Peter C. // BMJ: British Medical Journal (International Edition);5/7/2005, Vol. 330 Issue 7499, p1049 

    Presents a study comparing how allocation concealment is described in publications of randomized clinical trials and corresponding protocols. Aim of the study to estimate how often trial publications with unclear allocation concealment have adequate concealment according to the protocol; Review...

  • An Introduction to Clinical Trials. Robey, Randall R. // ASHA Leader;5/24/2005, Vol. 10 Issue 7, p6 

    The article presents information on the importance of clinical trials. A clinical trial is prospective research aimed at answering a specific question emerging out of clinical practice. The clinical question particularizes one or more populations and a new clinical protocol. For instance, a...

  • The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints Lassere, Marissa N. // Statistical Methods in Medical Research;Jun2008, Vol. 17 Issue 3, p303 

    There are clear advantages to using biomarkers and surrogate endpoints, but concerns about clinical and statistical validity and systematic methods to evaluate these aspects hinder their efficient application. Section 2 is a systematic, historical review of the biomarker-surrogate endpoint...

  • Intravenous Vitamin C. Moss, Ralph W. // Townsend Letter for Doctors & Patients;Oct2004, Issue 255, p24 

    Focuses on the study of U. S. National Institutes of Health (NIH) regarding the comparative effects of taking Vitamin C via intravenous route than taking it orally. Concentrations of blood and plasma when vitamin C is given intravenously; Clinical trials conducted on vitamin C; Award won by...

  • Grading Quality of Evidence and Strength of Recommendations: A Perspective. Ansari, Mohammed T.; Tsertsvadze, Alexander; Moher, David // PLoS Clinical Trials;Sep2009, Vol. 6 Issue 9, Special section p1 

    The authors comment on the quality and evidence-based compliance of the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) in rating in clinical trials. They say that the reliability of GRADE will not be questionable if its developers provided evidence that would prove...

  • Centre Selection for Clinical Trials and the Generalisability of Results: A Mixed Methods Study. Gheorghe, Adrian; Roberts, Tracy E.; Ives, Jonathan C.; Fletcher, Benjamin R.; Calvert, Melanie // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: The rationale for centre selection in randomised controlled trials (RCTs) is often unclear but may have important implications for the generalisability of trial results. The aims of this study were to evaluate the factors which currently influence centre selection in RCTs and...

  • Systematisches Review über Datenqualität und Protokoll- Compliance in klinischen Studien. Ohmann, Christian; Brosteanu, Oana; Pfistner, Beate; Houben, Peggy; Ihrig, Kristina; Meyer, Sandra; Paulus, Ursula; Strenge-Hesse, Anke; Zettelmeyer, Ulrike; Schwarz, Gabriele // GMS Medizinische Informatik, Biometrie und Epidemiologie;2008, Vol. 4, p1 

    For Investigator Initiated Trials (IITs) alternative risk-adapted monitoring strategies are discussed in order to fulfill rules and regulations, taking into consideration the restricted resources, In this systematic review investigations, presenting quantitative data about data quality and...

  • Vitamin D Deficiency Global Clinical Trials Review, H2 2011 -- Available Now!  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p31 

    The article presents a report on the clinical trials on the deficiency of vitamin D. The report provides elemental information and data associated to the trials and an overview of the trials and their recruitment status. It also mentions the lists of discontinued trials due to suspension,...

  • How well is the clinical importance of study results reported? An assessment of randomized controlled trials. Chan, Karen B.Y.; Man-Son-Hing, Malcom; Molnar, Frank J.; Laupacis, Andreas // CMAJ: Canadian Medical Association Journal;10/30/2001, Vol. 165 Issue 9, p1197 

    Background The interpretation of the results of randomized controlled trials (RCTs) has traditionally emphasized statistical significance rather than clinical importance. Our aim was to assess the quality of reporting of factors related to clinical importance in a sample of published RCTs....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics